{"id":"daivonex-scalp-solution","safety":{"commonSideEffects":[{"rate":null,"effect":"Irritation at application site"},{"rate":null,"effect":"Burning or stinging sensation"},{"rate":null,"effect":"Hypercalcemia (with excessive use)"}]},"_chembl":{"chemblId":"CHEMBL2108251","moleculeType":"Oligosaccharide"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Calcipotriol (the active ingredient) is a synthetic analogue of calcitriol (active vitamin D3) that modulates keratinocyte differentiation and proliferation by activating vitamin D receptors. This leads to normalization of the abnormal skin cell growth cycle seen in psoriasis and reduces inflammatory cytokine production, thereby improving scaling, erythema, and plaque formation on the scalp.","oneSentence":"Daivonex scalp solution is a vitamin D3 analogue that binds to vitamin D receptors on skin cells to reduce excessive cell proliferation and inflammation characteristic of psoriasis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:31:56.608Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Psoriasis of the scalp"}]},"trialDetails":[{"nctId":"NCT01195831","phase":"PHASE3","title":"Efficacy and Safety of Xamiol® Gel Compared to Calcipotriol Scalp Solution in Patients With Scalp Psoriasis","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2010-09","conditions":"Scalp Psoriasis","enrollment":244},{"nctId":"NCT02533973","phase":"PHASE4","title":"Long-term Treatment of Scalp Psoriasis With Xamiol® Gel in a Large Adult Chinese Population","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2015-09","conditions":"Psoriasis Vulgaris","enrollment":951},{"nctId":"NCT01445886","phase":"PHASE2, PHASE3","title":"Comparison of Indigo Naturalis Oil Extract and Calcipotriol Solution in Treating Psoriasis","status":"COMPLETED","sponsor":"Yin-ku Lin","startDate":"2011-01","conditions":"Nail Psoriasis","enrollment":33}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":11,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Daivonex® scalp solution","genericName":"Daivonex® scalp solution","companyName":"LEO Pharma","companyId":"leo-pharma","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Daivonex scalp solution is a vitamin D3 analogue that binds to vitamin D receptors on skin cells to reduce excessive cell proliferation and inflammation characteristic of psoriasis. Used for Psoriasis of the scalp.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}